Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of epinephrine injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial. Glenmark’s epinephrine injection USP, 10 mg/10 mL (1 mg/mL) ...
Following a placebo lead-in period, patients were randomly assigned to receive either oral baclofen (10 mg three times daily) or matching placebo for 4 weeks; after a washout period of 2 weeks ...
1Glenmark's Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial is only approved for the indication(s) listed in Glenmark's approved label. 2Market includes brand and all available ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results